Safinamide

Safinamide is a selective and reversible monoamine oxidase B (MAO-B) inhibitor with additional anticonvulsant and glutamate-modulating properties. It is approved for use in Parkinson’s disease and has shown neuroprotective effects in seizure and neurodegeneration models. Safinamide’s multimodal action makes it a promising candidate for treating motor and non-motor symptoms in neurodegenerative disorders.

Classification: Danger

GHS Hazard Statements:

• H301
• H318
• H400
• Precautionary Statement Codes
• P264, P264+P265, P270, P273, P280, P301+P316, P305+P354+P338, P317, P321, P330, P391, P405, and P501

Safinamide (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-625)

Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.

• Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
• Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
• Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
• QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
• Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity

To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).

Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).